Intra-articular Duration of Durolane™ after Single Injection into the Rabbit Knee.

Area of Science:

• Biomedical Engineering
• Orthopedics
• Pharmacokinetics

Background:

• Hyaluronic acid (HA) is crucial for joint lubrication and shock absorption.
• The intra-articular residence time of HA products influences their efficacy in treating osteoarthritis.
• Current HA formulations have varying durations of action, necessitating investigation into longer-lasting alternatives.

Purpose of the Study:

• To determine the intra-articular duration of Durolane™ in a rabbit model.
• To compare the residence time of Durolane™ with native HA and other modified HA products.
• To assess the safety profile of Durolane™ through histological analysis.

Main Methods:

• Radiolabeling of Durolane™ with Carbon-14 (¹⁴C) to track its presence.
• Intra-articular injection of ¹⁴C-labeled Durolane™ into rabbit knee joints.
• Measurement of remaining radioactivity at multiple time points to calculate elimination half-life and histological examination.

Main Results:

• Durolane™ exhibited first-order kinetics for elimination from the knee joint.
• The apparent half-life of Durolane™ was determined to be approximately 32 days.
• Histological analysis revealed no adverse morphological changes in the knee joints post-injection.

Conclusions:

• Durolane™ possesses a significantly longer intra-articular half-life (32 days) compared to previously reported HA products.
• The extended residence time suggests potentially improved therapeutic benefits for joint conditions.
• Durolane™ demonstrated a favorable safety profile in the rabbit knee joint model.